Galectin Therapeutics Inc $15.32

up +1.60


25/7/2014 04:00 PM  |  NASDAQ : GALT  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get GALT Trend Analysis - it has outperformed the S&P 500 by 193%

Partner Headlines

  1. Galectin Offers Results in Preclinical Model of GR-MD-02, Results Show ...

    Benzinga
  2. Galectin Therapeutics Completes Enrollment of Second Cohort of Phase 1 ...

    Benzinga
  3. Galectin Therapeutics Announces First Patient Dosed in Second Cohort of ...

    Benzinga
  4. MLV & Co Expects Positive News from Galectin Therapeutics

    Benzinga
  5. Benzinga's Volume Movers

    Benzinga
  6. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  7. Galectin Therapeutics Complet Enrollment in First Cohort of Phase 1 Trial ...

    Benzinga
  8. Market Wrap For January 10: Job Growth Weak, But Unemployment Falls

    Benzinga
  9. Benzinga's Volume Movers

    Benzinga
  10. Galectin Announces Early Warrant Exercise by 10X Fund, Issues Update on ...

    Benzinga
  11. UPDATE: Ascendiant Capital Initiates Coverage on Galectin Therapeutics ...

    Benzinga
  12. Benzinga's Top Initiations

    Benzinga
  13. Benzinga's Volume Movers

    Benzinga
  14. Morning Market Movers

    Benzinga
  15. Benzinga's Volume Movers

    Benzinga
  16. UPDATE: Aegis Capital Raises PT on Galectin Therapeutics Following Valuation ...

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Galectin Therapeutics Reports FDA Fast Track Designation for GR-MD-02

    Benzinga
  19. Galectin Therapeutics Says Anti-Galectin Drug Effective in Preclinical ...

    Benzinga
  20. Galectin Therapeutics Names Shlevin COO

    Benzinga
  21. Galectin Therapeutics Receives U.S. Patent for Potential Ground-Breaking ...

    Benzinga
  22. UPDATE: Dawson James Reiterates Buy Rating, Lowers PT on Galectin Therapeutics

    Benzinga
  23. ProShares Trust Ultra VIX Short Term Futures ETF, CTC Media Among Stocks ...

    FoxBusiness
Trading Center